EP0644765A4 - METAL POWDER COMPOSITIONS CONTAINING BINDERS FOR HIGH TEMPERATURE COMPRESSION. - Google Patents

METAL POWDER COMPOSITIONS CONTAINING BINDERS FOR HIGH TEMPERATURE COMPRESSION.

Info

Publication number: EP0644765A4
Authority: EP; European Patent Office
Prior art keywords: high temperature; metal powder; compositions containing; powder compositions; temperature compression
Prior art date: 1992-05-22
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP93914110A

Other languages

German (de)

French (fr)

Other versions

EP0644765A1 (en

Inventor

Kevin D Cooper

Craig Hammerberg

Kameron W Maxwell

Ben Y Tseng

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Genta Inc

University of Michigan Ann Arbor

Original Assignee

Genta Inc

University of Michigan Ann Arbor

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-05-22

Filing date

1993-05-21

Publication date

1997-02-26

1993-05-21 Application filed by Genta Inc, University of Michigan Ann Arbor filed Critical Genta Inc

1995-03-29 Publication of EP0644765A1 publication Critical patent/EP0644765A1/en

1997-02-26 Publication of EP0644765A4 publication Critical patent/EP0644765A4/en

Status Withdrawn legal-status Critical Current

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/12—Acyclic radicals, not substituted by cyclic structures attached to a nitrogen atom of the saccharide radical
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1136—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against growth factors, growth regulators, cytokines, lymphokines or hormones
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/15—Nucleic acids forming more than 2 strands, e.g. TFOs
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/312—Phosphonates
- C12N2310/3125—Methylphosphonates

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
Zoology (AREA)
General Engineering & Computer Science (AREA)
Epidemiology (AREA)
Biochemistry (AREA)
Wood Science & Technology (AREA)
Microbiology (AREA)
Rheumatology (AREA)
Biophysics (AREA)
Plant Pathology (AREA)
Endocrinology (AREA)
Physics & Mathematics (AREA)
Pain & Pain Management (AREA)
Ophthalmology & Optometry (AREA)
Crystallography & Structural Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Plant Substances (AREA)

EP93914110A 1992-05-22 1993-05-21 METAL POWDER COMPOSITIONS CONTAINING BINDERS FOR HIGH TEMPERATURE COMPRESSION. Withdrawn EP0644765A4 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US88773492A	1992-05-22	1992-05-22
US887734		1992-05-22
PCT/US1993/004917 WO1993024134A1 (en)	1992-05-22	1993-05-21	Treatment of cellular hyperproliferation by inhibition of interleukin-1

Publications (2)

Publication Number	Publication Date
EP0644765A1 EP0644765A1 (en)	1995-03-29
EP0644765A4 true EP0644765A4 (en)	1997-02-26

Family

ID=25391751

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP93914110A Withdrawn EP0644765A4 (en)	1992-05-22	1993-05-21	METAL POWDER COMPOSITIONS CONTAINING BINDERS FOR HIGH TEMPERATURE COMPRESSION.

Country Status (9)

Country	Link
EP (1)	EP0644765A4 (en)
JP (1)	JPH07508977A (en)
KR (1)	KR950701528A (en)
AU (1)	AU4388993A (en)
CA (1)	CA2136349A1 (en)
IL (1)	IL105741A0 (en)
MX (1)	MX9302951A (en)
NZ (1)	NZ253509A (en)
WO (1)	WO1993024134A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6159460A (en) *	1988-05-27	2000-12-12	Amgen Inc.	Method for treating interleukin-1 mediated diseases
US6858409B1 (en)	1988-05-27	2005-02-22	Amgen Inc.	Nucleic acids encoding interleukin-1 inhibitors and processes for preparing interleukin-1 inhibitors
US5075222A (en)	1988-05-27	1991-12-24	Synergen, Inc.	Interleukin-1 inhibitors
GB9405021D0 (en) *	1994-03-15	1994-04-27	Unilever Plc	Skin treatment composition
EP1199360A3 (en) *	1996-03-01	2002-05-02	Euroscreen S.A.	Active and inactive CC-chemokine receptors and nucleic acid molecules encoding said receptor
US6294170B1 (en)	1997-08-08	2001-09-25	Amgen Inc.	Composition and method for treating inflammatory diseases
DK0994743T3 (en) *	1997-07-10	2006-10-02	Therakos Inc	Treatment of inflammatory disorders of the intestine or bladder
US20040224893A1 (en) *	2003-05-06	2004-11-11	Li-Hsien Wang	Methods of using IL-1 antagonists to treat neointimal hyperplasia
US7897582B2 (en)	2003-05-23	2011-03-01	Isis Pharmaceuticals, Inc.	Oligonucleotide compositions and methods for the modulation of the expression of B7 protein
US7960355B2 (en)	2003-05-23	2011-06-14	Isis Pharmaceuticals, Inc.	Compositions and methods for the modulation of the expression of B7 protein
WO2006084145A2 (en) *	2005-02-02	2006-08-10	Regeneron Pharmaceuticals, Inc.	Methods of using il-1 antagonists to reduce c-reactive protein
GB0607189D0 (en) *	2006-04-10	2006-05-17	Polybiomed Ltd	interleukin IL 1ra composition

Citations (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1989006702A1 (en) *	1988-01-21	1989-07-27	Chemex Pharmaceuticals, Inc.	Selective inhibition of gene expression by photoactivatable oligonucleotides
WO1991015226A1 (en) *	1990-04-09	1991-10-17	The American National Red Cross	Rejuvenation compositions and methods for their use
WO1992021353A1 (en) *	1991-05-31	1992-12-10	Genta Incorporated	Compositions and delivery systems for transdermal administration of neutral oligomers
WO1993005071A1 (en) *	1991-08-30	1993-03-18	Sterling Winthrop Inc.	INTERLEUKIN 1β PROTEASE AND INTERLEUKIN 1β PROTEASE INHIBITORS

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5135917A (en) *	1990-07-12	1992-08-04	Nova Pharmaceutical Corporation	Interleukin receptor expression inhibiting antisense oligonucleotides

1993
- 1993-05-19 IL IL105741A patent/IL105741A0/en unknown
- 1993-05-20 MX MX9302951A patent/MX9302951A/en unknown
- 1993-05-21 WO PCT/US1993/004917 patent/WO1993024134A1/en not_active Ceased
- 1993-05-21 KR KR1019940704197A patent/KR950701528A/en not_active Withdrawn
- 1993-05-21 EP EP93914110A patent/EP0644765A4/en not_active Withdrawn
- 1993-05-21 CA CA002136349A patent/CA2136349A1/en not_active Abandoned
- 1993-05-21 AU AU43889/93A patent/AU4388993A/en not_active Abandoned
- 1993-05-21 NZ NZ253509A patent/NZ253509A/en not_active IP Right Cessation
- 1993-05-21 JP JP6500694A patent/JPH07508977A/en active Pending

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1989006702A1 (en) *	1988-01-21	1989-07-27	Chemex Pharmaceuticals, Inc.	Selective inhibition of gene expression by photoactivatable oligonucleotides
WO1991015226A1 (en) *	1990-04-09	1991-10-17	The American National Red Cross	Rejuvenation compositions and methods for their use
WO1992021353A1 (en) *	1991-05-31	1992-12-10	Genta Incorporated	Compositions and delivery systems for transdermal administration of neutral oligomers
WO1993005071A1 (en) *	1991-08-30	1993-03-18	Sterling Winthrop Inc.	INTERLEUKIN 1β PROTEASE AND INTERLEUKIN 1β PROTEASE INHIBITORS

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
AAPS (AMERICAN ASSOCIATION OF PHARMACEUTICAL SCIENTISTS) EIGHTH ANNUAL MEETING AND EXPOSITION, ORLANDO, FLORIDA, USA, NOVEMBER 14-18, 1993. *
HAMMERBERG, C. ET AL.: "Interleukin - 1 receptor antagonist in normal and psoriatic epidermis.", JOURNAL OF CLINICAL INVESTIGATION, (1992 AUG) 90 (2) 571-83., XP000615300 *
MANSON, J. ET AL.: "Modulation of interleukin 1beta gene expression using antisense phosphorothioate oligonucleotides", LYMPHOKINE RES. 9 (1990);35-42, XP002021245 *
MILLER, K. ET AL.: "In vitro transdermal flux and tissue distribution of interleukin 1-beta antisense methyl phosphonate oligonucleotide from topical formulations.", PHARMACEUTICAL RESEARCH (NEW YORK) 10 (10 SUPPL.). S252. ABSTRACT PDD7310, October 1993 (1993-10-01), XP002021246 *
See also references of WO9324134A1 *

Also Published As

Publication number	Publication date
JPH07508977A (en)	1995-10-05
WO1993024134A1 (en)	1993-12-09
AU4388993A (en)	1993-12-30
MX9302951A (en)	1994-07-29
EP0644765A1 (en)	1995-03-29
KR950701528A (en)	1995-04-28
IL105741A0 (en)	1993-09-22
NZ253509A (en)	1999-09-29
CA2136349A1 (en)	1993-12-09

Legal Events

Date	Code	Title	Description
1995-02-10	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
1995-03-29	17P	Request for examination filed	Effective date: 19941212
1995-03-29	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE
1997-02-26	A4	Supplementary search report drawn up and despatched	Effective date: 19970110
1997-02-26	AK	Designated contracting states	Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE
1999-10-13	17Q	First examination report despatched	Effective date: 19990830
2000-04-20	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2000-06-07	18D	Application deemed to be withdrawn	Effective date: 19991202

Publication	Publication Date	Title
NO943452D0 (en)	1994-09-16	Binder composition for powder coating
FI943562L (en)	1995-01-31	Radiation-curable binder composition for powder coating compositions
KR910014167A (en)	1991-08-31	Metal powder composition without segregation using polyvinylpyrrolidone binder
BR9507828A (en)	1997-09-16	Lubricant for powdered metal compositions powdered metal composition containing the lubricant method for obtaining sintered products by using the lubricant and using them
DE3873951D1 (en)	1992-10-01	TANTALUM POWDER CONTAINING METAL FLAKES.
EP0568021A3 (en)	1995-11-22	Binder composition
GB2073247B (en)	1983-10-26	Anti-wear sintered alloy
ZA831300B (en)	1983-11-30	Novel benzotriazole mixtures,processes for producing them,and their use as metal passivators
EP0644765A4 (en)	1997-02-26	METAL POWDER COMPOSITIONS CONTAINING BINDERS FOR HIGH TEMPERATURE COMPRESSION.
DE3060730D1 (en)	1982-09-30	Alkali metal silicate binder compositions
FI905292A7 (en)	1991-04-27	Thixotropic binder systems for thixotropic coating compositions
DE69015971D1 (en)	1995-02-23	Powder coating compositions.
GB2232412B (en)	1993-10-06	Stabilized metal oxide powder compositions
IT8020177A0 (en)	1980-02-26	COMPOSITION SUITABLE FOR THE COLORIMETRIC DETERMINATION OF METALS.
DE69103120D1 (en)	1994-09-01	Polyphenylene sulfide composition for powder coating.
GB2078788B (en)	1984-10-03	Compositions for coating metal surfaces
AU5784480A (en)	1981-01-08	Metal powder
MX9204272A (en)	1993-01-01	COMPOSITIONS FOR THERMOSTABLE POWDER COATINGS.
DE69018919D1 (en)	1995-06-01	Kiln for powder coatings.
NO822311L (en)	1983-01-03	HYDROCARBON COMPOSITIONS CONTAINING HETEROAROMATIC NITROGEN COMPOUNDS AS ANTIOXYDICTIONS / METAL DEACTIVATORS / ELECTRICAL ISOLATORS
DE69016563D1 (en)	1995-03-16	Metal coating compositions containing linear polyester-polyurethane.
FI964668L (en)	1997-01-21	Metal filter for high temperature applications
DE3469282D1 (en)	1988-03-17	Self-receipting continuous stationery for point-of-sale terminal
ZA815344B (en)	1982-08-25	Binder composition
IT8221126A0 (en)	1982-05-07	U-SHAPED METALLIC GRAPPA.